Streetbeat News

Products Services

ACB

CGC

The Drug Enforcement Administration (DEA) plans to significantly increase domestic production of delta-9 THC and other cannabinoids for research purposes in 2024. The agency also plans to maintain high levels of psychedelics production. The DEA has proposed nearly doubling the amount of psilocybin, psilocyn, and delta-9 THC manufactured compared to initial levels set for this year, while quintupling the production of ibogaine. The DEA's move comes amid a transition away from cannabinoid imports to domestic manufacturing.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 6:45 pm

OLIT

OTLK

The article lists the stocks that gained and lost the most in Thursday's mid-day session. Some of the top gainers include OmniLit Acquisition Corp., Panbela Therapeutics, Inc., Lemonade, Inc., and Aware, Inc. due to positive news such as merger approvals, publication of clinical data, and strong quarterly results. On the other hand, Outlook Therapeutics, Inc., Confluent, Inc., Remitly Global, Inc., and Acurx Pharmaceuticals, Inc. were among the top losers due to negative news such as additional clinical trials required for approval, mixed financial results, and disappointing efficacy results from a Phase 2 trial.

Portfolio Pulse from Lisa Levin

November 02, 2023 | 6:26 pm

ABBV

BKH

FRT

KMB

KNGS

KVUE

LEG

MMM

SON

SWK

TGT

Roundhill Investments has launched the Roundhill S&P Dividend Monarchs ETF (NYSE:KNGS), the first-ever U.S. listed ETF to track the performance of Dividend Monarchs, a group of U.S. blue chip companies that have grown their dividends for 50+ consecutive years. The ETF includes 36 stock holdings, with top holdings including Leggett & Platt Inc (NYSE:LEG), 3M Co (NYSE:MMM), Federal Realty Investment Trust (NYSE:FRT), Black Hills Corp (NYSE:BKH), Stanley Black & Decker (NYSE:SWK), Sonoco Products (NYSE:SON), Target Corp (NYSE:TGT), Kimberly-Clark Corp (NYSE:KMB), AbbVie Inc (NYSE:ABBV), and Kenvue Inc (NYSE:KVUE).

Portfolio Pulse from Chris Katje

November 02, 2023 | 6:25 pm

CMPS

COMPASS Pathways plc (NASDAQ:CMPS) reported Q3 2023 financial results, showing a 67% increase in cash and cash equivalents to $248.0 million and a long-term debt of $28.4 million. The company's net loss and R&D expenses have also increased. COMPASS recently raised $125 million in gross proceeds from a private placement, which, along with a $50 million term loan facility and share sales, extends its runway to late 2025. The company's synthetic psilocybin therapeutic COMP360 is progressing in its Phase 3 clinical program for Treatment-Resistant Depression (TRD).

Portfolio Pulse from Lara Goldstein

November 02, 2023 | 6:16 pm

LLY

Eli Lilly has announced that Mounjaro, the first and only single molecule GIP and GLP-1 receptor agonist for the treatment of adults with Type 2 diabetes, is now available in Canada.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 5:33 pm

STLA

TSLA

WKSP

Toyota Motor Corporation (TM) has raised its full-year fiscal outlook due to strong hybrid demand, despite a slowdown in EV demand in the U.S. Worksport Ltd (WKSP, WKSPW) is preparing for the alpha release of its COR portable battery system. Toyota's Q2 revenue grew 24% YoY to $75.7 billion, with operating profit expanding over 155% YoY to $9.5 billion. Toyota has also raised its annual profit guidance from 3 trillion yen to 4.5 trillion yen ($29.8 billion). Meanwhile, Ford (F), General Motors (GM), and Stellantis (STLA) have suffered from a UAW strike, with Tesla (TSLA) potentially benefiting from a slower EV rollout from these automakers.

Portfolio Pulse from Upwallstreet

November 02, 2023 | 5:14 pm

SPCE

Virgin Galactic Holdings, Inc. (NYSE:SPCE) has announced the successful completion of its sixth space mission in six months, and tenth overall. The mission, named 'Galactic 05', saw the company's spaceship converted into a suborbital lab for space-based scientific research for the second time. The company plans to use insights from the mission to enhance the research capabilities of its future Delta-class spaceships.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 5:10 pm

ALPN

Alpine Immune Sciences has presented the first clinical data of povetacicept in autoimmune glomerulonephritis at ASN Kidney Week, which has led to an increase in its share price.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 5:04 pm

SGEN

Seagen Inc. (NASDAQ:SGEN) announced that it will present new data for its drug ADCETRIS in combination with immunotherapy for Hodgkin lymphoma at the 2023 ASH Annual Meeting. The company will also unveil a novel CD30-directed antibody-drug conjugate, SGN-35C. The data will include 12- and 24-month progression free survival data for ADCETRIS and immunotherapy combination in early and advanced stage classical Hodgkin lymphoma. ADCETRIS is a proven foundation of care for certain CD30-expressing lymphomas with more than 120,000 patients treated globally across seven indications.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 5:01 pm

CZR

DKNG

FOX

FOXA

PDYPY

The Texas Rangers won the 2023 World Series, marking their first championship in franchise history. The victory resulted in significant payouts for bettors who backed the team at the start of the season. The games were broadcast on Fox Corp. owned Fox. Bettors who placed bets on FanDuel, a unit of Flutter Entertainment, and Caesars Entertainment Inc also saw significant returns. DraftKings Inc has released odds for the 2024 World Series.

Portfolio Pulse from Chris Katje

November 02, 2023 | 4:56 pm